Complete Integrity Implant System is now fully cleared; targeting launch in Q1-2024 Integrity is highly differentiated by its knitted structure, resulting in higher strength and greater regenerative ...
BEDFORD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the Osteoarthritis (“OA”) Pain Management and Regenerative Solutions space focused on ...
Anika Therapeutics (ANIK) announced the divestiture of its Arthrosurface business and the intention to divest of the Parcus Medical business. These decisions are the result of the Company’s ongoing ...
Anika Therapeutics reports Q1 2025 revenue of $26.2 million, with an 18% rise in Commercial Channel revenue. Anika Therapeutics reported a first quarter 2025 revenue of $26.2 million, reflecting a 10% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback